Chengdu easton
WebPhone Number :+86-28-67585121. Chengdu Easton Biopharmaceuticals provides chemical raw materials, chemical drugs, and biological drugs, including anesthesia and analgesia, … WebGet the latest Chengdu Easton Biopharmctcls Co Ltd (688513) real-time quote, historical performance, charts, and other financial information to help you make more informed …
Chengdu easton
Did you know?
WebJan 23, 2024 · Chengdu Easton Biopharmaceuticals Co. Ltd. has synthesized ATR kinase inhibitors reported to be useful for the treatment of cancer. BioWorld Science Cancer … WebChengdu Easton Biopharmaceuticals Co., Ltd. China Easton Pharmaceutical Co., Ltd. is a new leading pharmaceutical company, engaging in development, manufacture and …
WebEaston Biopharmaceuticals Location: China Founded in 2009 "Founded in 2009 and home for over 800 employees, Chengdu Easton Biopharmaceuticals Co., Ltd (registered capital of CNY 90millon) is a high-tech pharmaceutical company with focus on research, development, manufacturing and distribution. WebAug 21, 2024 · China-based pharma Chengdu Easton Biopharmaceuticals is planning to raise around $193 million in its Star Market initial public offering (IPO), the media …
WebChengdu Easton Biopharmaceuticals Co.,Ltd. was founded in 2009, with 5 wholly owned subdsidiary companies and more than 1000 staffs. Easton Biopharmaceuticals was listed in the Shanghai Exchange Stock Sci-Tech Innovation Board (SSE START market) in September, 2024 (Stock code: 688513). WebApr 7, 2024 · Chengdu Easton Biopharmctcls Co Ltd; Assure Tech Hangzhou Co Ltd; Lepu Biopharma Co Ltd; Jiangsu Recbio Technology Co Ltd; Piramal Pharma Ltd; Beijing Foyou Pharma Co Ltd; Save Clear. Go to Interactive chart. Events & Activity. MEGA:SET price reached a new 52-week low of 41.25 at 17:19 BST Apr 05 2024;
WebMar 22, 2024 · Chengdu Easton Biopharmaceuticals Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical raw …
WebAug 31, 2024 · China’s Chengdu Easton Biopharmaceuticals is planning to raise around $193 million in its Star Market initial public offering (IPO), the media reported. Easton is offering 30.09 million shares at $6.4 per … tem akademieWebNov 25, 2024 · Chengdu Easton Biopharmaceuticals Co. Ltd. has described proteolysis targeting chimera (PROTAC) compounds comprising a cereblon (CRBN) ligand binding … tema kaamatan 2022WebChengdu Easton Biopharmaceuticals Co.,Ltd. Founded in 2009 and home for about 1000 employees, Easton Biopharmaceuticals (registered capital of CNY 90millon) is a high … temak aeWebChengdu is the largest trade center in western China with a market covering all of Sichuan province, exerting influence on a population of 250 million in six provinces, cities, and … tema kahuluganWebJan 28, 2024 · Chengdu Easton Biopharmaceuticals Co., Ltd. Attractive Opportunities In the Bisoprolol Fumarate API Market: The Global Bisoprolol Fumarate API market is anticipated to rise at a considerable rate... temakakerWebMar 19, 2024 · Chengdu Easton Bio Pharmaceuticals Co.,Ltd focuses on the R&D, production and sales of active pharmaceutical ingredients and chemical drug … temakalasWebApr 8, 2024 · Chengdu Easton Biopharmaceuticals Co,Ltd Information provided by (Responsible Party): Chengdu Easton Biopharmaceuticals Co,Ltd Study Details Tabular View No Results Posted Disclaimer How to Read a Study Record No Study Results Posted on ClinicalTrials.gov for this Study To Top temakalendern